Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single Dose Clonazepam vs Intermittent Diazepam for Recurrent Febrile Seizures
NCT04364321Unknown
- Sponsor
- Queen Sirikit National Institute of Child Health
- Start
- May 2020
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, single-blind trial of clonazepam in febrile seizures (FS) (2 arms), sponsored by Queen Sirikit National Institute of Child Health. Primary endpoint: Recurrent rate of febrile seizures at 12 months. Status: unknown.
02
Drugs
clonazepam
03
Conditions
febrile seizures (FS)
Beyond the preview
Go deeper on NCT04364321.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04364321.